[The antimalarial effects of piperaquine phosphate and sulphadoxine composite as tested in Hainan Island (author's transl)].
D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000009:adverse effects / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*; D010879:Piperazines
D000962:Antimalarials; D004338:Drug Combinations; D011804:Quinolines; D013413:Sulfadoxine; D013424:Sulfanilamides; C034759:piperaquine; D010879:Piperazines